Telomerase Promoter Mutations in Cancer: An Emerging Molecular Biomarker?

Virchows Archiv - Germany
doi 10.1007/s00428-014-1608-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Distinct Profiles of TERT Promoter Mutations and Telomerase Expression in Head and Neck Cancer and Cervical Carcinoma

International Journal of Cancer
Cancer ResearchOncology
2018English

Emerging Patterns of Somatic Mutations in Cancer

Nature Reviews Genetics
GeneticsMolecular Biology
2013English

Periostin: An Emerging Biomarker for Allergic Diseases

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Long Non-Coding RNA PVT1: Emerging Biomarker in Digestive System Cancer

Cell Proliferation
MedicineCell Biology
2017English

Visuospatial Perception: An Emerging Biomarker for Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2012English

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

Cancers
Cancer ResearchOncology
2019English

Ovarian Cancer: Emerging Molecular-Targeted Therapies

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

YKL-40 - An Emerging Biomarker in Cardiovascular Disease and Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2009English

Mutations in the SOD2 Promoter Reveal a Molecular Basis for an Activating Protein 2-Dependent Dysregulation of Manganese Superoxide Dismutase Expression in Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy